Health Technology Assessment brings clinical evidence together with cost-effectiveness, budget impact, equity, ethics and long-term value. This is particularly relevant to innovative pharmaceuticals, advanced therapies, medical devices, digital health, AI-enabled technologies and other high-cost interventions.
Build the evidence plan early
- Identify the patient population and the unmet need the technology addresses.
- Define outcomes that are meaningful to clinicians, patients and payers.
- Prepare health-economic and budget-impact evidence alongside the clinical story.
- Connect the value proposition to coding, reimbursement and implementation planning.
Companies that coordinate regulatory, medical, HEOR and market-access work earlier are better placed to answer the questions that follow approval.
